Fujian Cancer Hospital
Fuzhou, Fujian, China
Hospital in Fuzhou
134 Dongjie St, Gulou District, Fuzhou, Fuzhou, Fujian, 350001
About Fujian Cancer Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
22
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
19
BeiGene
15
Fujian Cancer Hospital
13
Shanghai Junshi Bioscience Co., Ltd.
7
Xiamen Amoytop Biotech Co., Ltd.
7
Fujian Provincial Hospital
6
Merck Sharp & Dohme LLC
6
Pfizer
6
Fuzhou General Hospital
5
Nanfang Hospital of Southern Medical University
5
Clinical Trials at Fujian Cancer Hospital
During the past decade, Fujian Cancer Hospital conducted 186 clinical trials. In the 10-year time frame, 186 clinical trials started and 20 clinical trials were completed, i.e. on
average, 10.8% percent of trials that started reached the finish line to date. In the past 5 years, 106 clinical trials started and 12 clinical trials were completed. i.e. 11.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
Safety and Efficacy of Palonosetron in Preventing Chemotherapy-induced Nausea and Vomiting
2006-04-01
2006-10-01
Completed
144
Drotaverine Hydrochloride Versus Hyoscine-N-butylbromide for Duodenal Antimotility During Endoscopic Retrograde Cholangiopancreatography (ERCP)
2008-08-01
2009-07-01
Completed
650
Cetuximab With Radiotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck in Chinese Subjects
2009-02-01
2014-05-01
Completed
70
A Comparison of the Pacemaker Automatic Features in Reduction of Ventricular Pacing
2009-06-01
2014-04-01
Completed
385
Tranexamic Acid in Clopidogrel Exposure to Decrease Hemorrhage and Transfusion
2010-01-01
2011-10-01
Completed
552
Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer
2009-10-01
2016-08-01
Unknown status
480
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fujian Cancer Hospital" #1 sponsor was "Hoffmann-La Roche" with 22 trials, followed by "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 19 trials
sponsored, "BeiGene" with 15 trials sponsored, "Fujian Cancer Hospital" with 13 trials sponsored and "Shanghai Junshi Bioscience Co., Ltd."
with 13 trials sponsored. Other sponsors include 152 different institutions and
companies that sponsored additional 93 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fujian Cancer Hospital"
#1 collaborator was "West China Hospital" with 5 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 4 trials as a collaborator, "Fujian Cancer Hospital" with 4 trials as a collaborator, "Guangdong Provincial People's Hospital" with 4 trials as a collaborator and "Nanfang Hospital of Southern Medical University" with 4 trials as a collaborator. Other collaborators include 141 different institutions and companies that were
collaborators in the rest 123 trials.
Clinical Trials Conditions at Fujian Cancer Hospital
According to Clinical.Site data, the most researched conditions in "Fujian Cancer Hospital" are
"Gastric Cancer" (10 trials), "Non-small Cell Lung Cancer" (8 trials), "Nasopharyngeal Carcinoma" (6 trials), "Non-Small Cell Lung Cancer" (6 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Fujian Cancer Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Fujian Cancer Hospital
Most popular intervention types in "Fujian Cancer Hospital" are "Drug" (195 trials), "Biological" (14 trials), "Procedure" (14 trials), "Other" (12 trials) and "Radiation" (12 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (37 trials), "Cisplatin" (17 trials), "Tislelizumab" (13 trials), "Atezolizumab" (12 trials) and "Anlotinib" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Fujian Cancer Hospital
The vast majority of trials in "Fujian Cancer Hospital" are
214 trials for "All" genders, 17 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Fujian Cancer Hospital
Currently, there are 129 active trials in "Fujian Cancer Hospital".
10 are not yet recruiting,
76 are recruiting,
40 are Active, not recruiting,
and 3 are Enrolling by invitation.
In total, there were 46 completed trials in Fujian Cancer Hospital,
undefined suspended trials,
and 10 terminated clinical trials to date.
Out of the total trials that were conducted in Fujian Cancer Hospital, 26 "Phase 1"
clinical trials were conducted, 84 "Phase 2" clinical
trials and 97 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 11 trials, and there were
also 17 trials that are defined as “Not Applicable".
Departments of Fujian Cancer Hospital
Fujian Cancer Hospital has several departments that took part in Clinical trials: "the Department of Cardiovascular Surgery" - 3 trials
Departments List
Name
City
Trials